EMAIL THIS PAGE TO A FRIEND

Scientific reports

Delivery of miR-34a by chitosan/PLGA nanoplexes for the anticancer treatment of multiple myeloma.


PMID 26620594

Abstract

The encapsulation of miR-34a into chitosan/PLGA nanoparticles in order to obtain nanoplexes useful for the modulation of the biopharmaceutical features of the active compound was studied. The nanoplexes were obtained through nanoprecipitation and were characterized by a mean diameter of ~160 nm, a good size distribution and a positive surface charge. The structure of the nanoparticles allowed a high level of entrapment efficiency of the miR-34a and provided protection of the genetic material from the effects of RNase. A high degree of transfection efficiency of the nanoplexes and a significant in vitro antitumor effect against multiple myeloma cells was demonstrated. The therapeutic properties of the nanoplexes were evaluated in vivo against human multiple myeloma xenografts in NOD-SCID mice. The systemic injection of miR-34a mimic-loaded nanoparticles significantly inhibited tumor growth and translated into improved survival of the laboratory mice. RT-PCR analysis carried out on retrieved tumors demonstrated the presence of a high concentration of miR-34a mimics. The integrity of the nanoplexes remained intact and no organ toxicity was observed in treated animals.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

74875
8-Octanoyloxypyrene-1,3,6-trisulfonic acid trisodium salt, suitable for fluorescence, ≥90% (HPCE)
C24H21Na3O11S3
D2650
Dimethyl sulfoxide, Hybri-Max, sterile-filtered, BioReagent, suitable for hybridoma, ≥99.7%
C2H6OS
D8418
Dimethyl sulfoxide, for molecular biology
C2H6OS
D4540
Dimethyl sulfoxide, ≥99.5% (GC), plant cell culture tested
C2H6OS
D1435
Dimethyl sulfoxide, meets EP testing specifications, meets USP testing specifications
C2H6OS
D9170
Dimethyl sulfoxide, PCR Reagent
C2H6OS
D2438
Dimethyl sulfoxide, sterile-filtered, BioPerformance Certified, meets EP, USP testing specifications, suitable for hybridoma
C2H6OS
276855
Dimethyl sulfoxide, anhydrous, ≥99.9%
C2H6OS
41639
Dimethyl sulfoxide, BioUltra, for molecular biology, ≥99.5% (GC)
C2H6OS
673439 Dimethyl sulfoxide solution, 50 wt. % in H2O
C2H6OS
E8751
Ethidium bromide, ~95% (HPLC)
C21H20BrN3
E7637
Ethidium bromide, BioReagent, for molecular biology, powder
C21H20BrN3
E1510
Ethidium bromide solution, BioReagent, for molecular biology, 10 mg/mL in H2O
C21H20BrN3
E1385
Ethidium bromide solution, BioReagent, for molecular biology, 500 μg/mL in H2O
C21H20BrN3
46067
Ethidium bromide solution, for fluorescence, ~1% in H2O
C21H20BrN3
46047
Pyridaben, PESTANAL®, analytical standard
C19H25ClN2OS
74255
Sodium dodecyl sulfate, dust-free pellets, suitable for electrophoresis, for molecular biology, ≥99.0% (GC)
C12H25NaO4S
L3771
Sodium dodecyl sulfate, BioReagent, suitable for electrophoresis, for molecular biology, ≥98.5% (GC)
C12H25NaO4S
L6026
Sodium dodecyl sulfate, BioXtra, ≥99.0% (GC)
C12H25NaO4S
436143
Sodium dodecyl sulfate, ACS reagent, ≥99.0%
C12H25NaO4S
L4509
Sodium dodecyl sulfate, ReagentPlus®, ≥98.5% (GC)
C12H25NaO4S
L5750
Sodium dodecyl sulfate, 92.5-100.5% based on total alkyl sulfate content basis
C12H25NaO4S
71725
Sodium dodecyl sulfate, BioUltra, for molecular biology, ≥99.0% (GC)
C12H25NaO4S
71729
Sodium dodecyl sulfate, ≥98.0% (GC)
C12H25NaO4S
71717
Sodium dodecyl sulfate, tested according to NF, mixture of sodium alkyl sulfates consisting mainly of sodium dodecyl sulfate
C12H25NaO4S
62862
Sodium dodecyl sulfate, ≥90%
C12H25NaO4S
75746
Sodium dodecyl sulfate, ≥99.0% (GC), dust-free pellets
C12H25NaO4S
71736
Sodium dodecyl sulfate solution, BioUltra, for molecular biology, 10% in H2O
C12H25NaO4S
05030
Sodium dodecyl sulfate solution, BioUltra, for molecular biology, 20% in H2O
C12H25NaO4S